NOS3 rs2070744: Understanding the -786T>C Promoter Variant
The rs2070744 variant is a single nucleotide polymorphism located in the promoter region of the NOS3 gene. It is frequently studied for its potential association with endothelial nitric oxide synthase expression and various cardiovascular health outcomes.
What each genotype means
Typical NOS3 promoter activity
This genotype represents the common version of the NOS3 promoter region. Research suggests this version is associated with standard levels of endothelial nitric oxide synthase transcription compared to the C allele. Please note that cardiovascular health is influenced by many genetic and lifestyle factors, and this result does not guarantee any specific health outcome.
This is the most common genotype in many populations, though frequencies vary significantly by ancestry.
Reduced promoter activity potential
Carrying one copy of the C allele may be associated with reduced transcription of the endothelial nitric oxide synthase gene. Some studies have linked the C allele to an increased risk of conditions like essential hypertension or coronary artery spasm, though findings are mixed and often depend on specific population backgrounds. Discuss any concerns regarding cardiovascular health or blood pressure management with your clinician.
This heterozygous genotype is common, appearing in a significant portion of individuals across many global populations.
Increased risk association
Individuals with this genotype carry two copies of the C allele, which has been associated in some research with impaired endothelial nitric oxide synthase transcription. This variant is studied for its potential link to susceptibility for coronary artery spasm and essential hypertension. Because these associations are complex and influenced by environmental factors, please consult with a healthcare provider to discuss your cardiovascular risk profile.
This genotype is less common than the TT or TC combinations in many populations, with frequencies varying by ancestry.
What is rs2070744?
The rs2070744 variant, often referred to as -786T>C, is a specific genetic change where a thymine (T) is replaced by a cytosine (C) at position -786 in the promoter region of the NOS3 gene. A promoter region is a segment of DNA located upstream of a gene that acts as an on-off switch, controlling how much of the gene's product is created. Because this variant sits in a regulatory area, researchers have long hypothesized that it may influence the transcription of the NOS3 gene. By altering the binding sites for transcription factors, the C allele is thought by some investigators to potentially reduce the efficiency of the gene's expression. This makes it a common subject of interest in studies examining how subtle variations in our genetic code might influence physiological processes, particularly those related to the cardiovascular system and the regulation of blood vessel function.
The Role of the NOS3 Gene
The NOS3 gene provides instructions for making an enzyme called endothelial nitric oxide synthase (eNOS). This enzyme is primarily found in the cells that line the interior surface of blood vessels, known as endothelial cells. Its main job is to produce nitric oxide, a critical signaling molecule that helps blood vessels relax and widen, a process called vasodilation. By promoting vasodilation, eNOS plays a vital role in maintaining healthy blood pressure levels and ensuring proper blood flow throughout the body. When eNOS activity is reduced, it can impair the ability of blood vessels to respond to changes in demand, which is why researchers investigate whether genetic variants like rs2070744 might contribute to differences in cardiovascular health. Understanding this gene is essential for grasping how the body manages vascular tone and overall circulatory health.
Research and Cardiovascular Associations
Scientific research into rs2070744 has produced mixed and sometimes conflicting results regarding its impact on health. Many studies have explored its association with conditions such as hypertension, coronary artery disease, and coronary collateral circulation. While some meta-analyses have suggested a statistical link between the C allele and an increased risk for certain cardiovascular conditions, other studies have found no significant association at all. The evidence is considered limited because the effects observed in one population are not always replicated in others, and the influence of this single variant is likely small compared to the combined impact of lifestyle, environment, and other genetic factors. Because of these inconsistencies, it is difficult to draw definitive conclusions about the clinical significance of this variant for any individual. It remains a subject of ongoing investigation rather than a established diagnostic marker.
What This Information Means for You
If you have information about your rs2070744 genotype, it is important to view it within the context of your overall health. Genetic variants are only one piece of a very complex puzzle that includes your diet, physical activity, smoking status, and family history. Because the scientific evidence for this specific variant is mixed and often shows only weak statistical associations, it cannot be used to predict your personal risk of developing cardiovascular disease or to guide medical treatment. You should never make changes to your health regimen or medication based on this information without consulting a healthcare professional. If you have concerns about your cardiovascular health, the most effective steps involve focusing on evidence-based lifestyle choices, such as maintaining a heart-healthy diet and regular exercise, and discussing your specific risk factors with your doctor.
How common is this variant?
The C allele is relatively common, with a minor allele frequency of approximately 0.35 to 0.40 in European populations, while it is observed at a lower frequency of about 0.12 in East Asian populations.
Frequently asked questions
Is rs2070744 a diagnostic test for heart disease?
No, rs2070744 is not a diagnostic test. The associations between this variant and heart disease are based on statistical trends in large groups and cannot predict an individual's health outcome.
Should I change my blood pressure medication based on my genotype?
You should never change your medication based on genetic information. Always discuss your current treatment plan and any concerns with your clinician or pharmacist.
Why do different studies show different results for this variant?
Genetic studies often vary due to differences in population ancestry, sample sizes, and environmental factors. These inconsistencies are common in complex traits where many genes and lifestyle factors interact.
Does having the CC genotype mean I will have high blood pressure?
No, having a specific genotype does not guarantee a health outcome. Many people with the CC genotype have normal blood pressure, as cardiovascular health is influenced by many factors beyond a single SNP.
Sources & further reading
Educational information only, last refreshed 10/26/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2070744?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in NOS3
Also known as Glu298Asp (894G>T), this variant affects endothelial nitric oxide synthase cleavage and vascular tone, modulating exercise-induced vasodilation and aerobic performance.
An intronic endothelial nitric oxide synthase polymorphism that influences vascular tone, exercise-induced vasodilation, and aerobic endurance performance.
Commonly studied variant in the endothelial nitric oxide synthase gene, associated with cardiovascular traits.
Endothelial nitric oxide synthase variant implicated in blood flow response and muscle capillarization during aerobic training.
Promoter-adjacent polymorphism affecting endothelial nitric oxide synthase transcription, modulating exercise-induced vasodilation and aerobic trainability.
The Glu298Asp variant in the NOS3 gene is associated with altered nitric oxide production and may influence susceptibility to cardiovascular conditions like hypertension and coronary artery disease.